NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3033% below fair value
$10.73−0.41 (-3.68%)
Close on Nov 18, 2026Market cap $1.25BP/E –Yield –
NovoCure operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NovoCure's operating cash flow for the twelve months ending Sep 30, 2026 was -$722.00K. For fiscal 2025 it was -$49.03M. The highest annual figure on record is $99.15M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.03M | – |
| FY2024 | Dec 31, 2024 | -$26.37M | – |
| FY2023 | Dec 31, 2023 | -$73.34M | -338.2% |
| FY2022 | Dec 31, 2022 | $30.79M | -62.8% |
| FY2021 | Dec 31, 2021 | $82.76M | -16.5% |
| FY2020 | Dec 31, 2020 | $99.15M | +272.5% |
| FY2019 | Dec 31, 2019 | $26.62M | – |
| FY2018 | Dec 31, 2018 | -$1.87M | – |
| FY2017 | Dec 31, 2017 | -$33.13M | – |
| FY2016 | Dec 31, 2016 | -$107.59M | – |
| FY2015 | Dec 31, 2015 | -$99.88M | – |
| FY2014 | Dec 31, 2014 | -$74.24M | – |
| FY2013 | Dec 31, 2013 | -$52.72M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $22.67M | +10.2% |
| Q2 FY2026 | Jun 30, 2026 | $8.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.52M | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $20.57M | +98.3% |
| Q2 FY2025 | Jun 30, 2025 | -$15.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$35.67M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.45M | – |
| Q3 FY2024 | Sep 30, 2024 | $10.38M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$31.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.56M | – |
| Q3 FY2023 | Sep 30, 2023 | -$19.31M | -186.1% |
| Q2 FY2023 | Jun 30, 2023 | -$22.74M | -244.3% |
| Q1 FY2023 | Mar 31, 2023 | -$16.73M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.71M | -125.7% |
| Q3 FY2022 | Sep 30, 2022 | $22.42M | -8.1% |
| Q2 FY2022 | Jun 30, 2022 | $15.76M | -39.8% |
| Q1 FY2022 | Mar 31, 2022 | -$3.69M | -120.7% |
| Q4 FY2021 | Dec 31, 2021 | $14.40M | -73.1% |
| Q3 FY2021 | Sep 30, 2021 | $24.40M | -21.2% |
| Q2 FY2021 | Jun 30, 2021 | $26.17M | +105.4% |
| Q1 FY2021 | Mar 31, 2021 | $17.78M | +808.5% |
| Q4 FY2020 | Dec 31, 2020 | $53.48M | +668.2% |
| Q3 FY2020 | Sep 30, 2020 | $30.97M | +107.7% |
| Q2 FY2020 | Jun 30, 2020 | $12.74M | +40.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.96M | – |
| Q4 FY2019 | Dec 31, 2019 | $6.96M | -58.6% |
| Q3 FY2019 | Sep 30, 2019 | $14.91M | +164.4% |
| Q2 FY2019 | Jun 30, 2019 | $9.07M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.32M | – |
| Q4 FY2018 | Dec 31, 2018 | $16.81M | – |
| Q3 FY2018 | Sep 30, 2018 | $5.64M | +121.4% |
| Q2 FY2018 | Jun 30, 2018 | -$7.49M | – |
| Q1 FY2018 | Mar 31, 2018 | -$16.82M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.90M | – |
| Q3 FY2017 | Sep 30, 2017 | $2.55M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$26.91M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.73M | – |
See a number that looks wrong?